SEGMENTS

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

SEGMENTS

  5. SEGMENTS

Operating segments are defined as components of an enterprise about which separate financial information is available, that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. At the present time, our financial services activities are reported under our other business activities. Our biohealth revenues include the sale of consumer products. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision-maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the nine months ended September 30, 2021 and 2020:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Nine Months Ended September 30, 2021
Revenue	$	12,026,069		$	-		$	4,919,844		$	-		$	16,945,913
Cost of Sales		(8,291,698	)		-			(218,507	)		-			(8,510,205	)
Gross Margin		3,734,371			-			4,701,337			-			8,435,708
Operating Expenses		(901,236	)		(173,594	)		(3,451,152	)		(8,940,432	)		(13,466,414	)
Operating Income (Loss)		2,833,135			(173,594	)		1,250,185			(8,940,432	)		(5,030,706	)
Other Income (Expense)		(9,063	)		403,000			(33,960,503	)		(53,727,340	)		(87,293,906	)
Net Income (Loss) Before Income Tax		2,824,072			229,406			(32,710,318	)		(62,667,772	)		(92,324,612	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Nine Months ended September 30, 2020
Revenue	$	7,148,786		$	-		$	31,133		$	-		$	7,179,919
Cost of Sales		(5,603,164	)		-			(6,139	)		-			(5,609,303	)
Gross Margin		1,545,622			-			24,994			-			1,570,616
Operating Expenses		(634,254	)		(87,972	)		(388,083	)		(3,424,869	)		(4,535,178	)
Operating Income (Loss)		911,368			(87,972	)		(363,089	)		(3,424,869	)		(2,964,562	)
Other Income (Expense)		(2,646	)		115			(10,211,916	)		433,844			(9,780,603	)
Net Income (Loss) Before Income Tax		908,722			(87,857	)		(10,575,005	)		(2,991,025	)		(12,745,165	)
September 30, 2021
Cash and Restricted Cash	$	7,951,918		$	228,627		$	2,845,805		$	61,914,783		$	72,941,133
Total Assets		42,348,896			1,252,457			18,136,991			113,397,797			175,136,141
December 31, 2020
Cash and Restricted Cash	$	8,150,769		$	158,058		$	1,590,265		$	21,836,387		$	31,735,479
Total Assets		28,954,484			158,160			524,603			78,076,498			107,713,745